Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases.
To contact Derek, email him directly: email@example.com (mailto:firstname.lastname@example.org)
I work in the financial services industry and am a long-time investor in the biotech sector. Harvard JD. Expert on option valuation and accounting for executive compensation. Moderator of the Biotech Valuation thread at SIlicon Investor, which has had over 30,000 posts since its inception:
See Seeking Alpha's policy on anonymous authors: http://seekingalpha.com/article/69847-seeking-alpha-policy-on-anonymous-authorship
Currently a partner of HarborView Capital Management LLC, I have been in the business since 1984 where I started in the capital markets division of Shearson Lehman Brothers. From 1994 until 2005 I was the General Partner of Gulfstream Partners L.P. The fund strategy was a long/short equity across all sectors and all market caps. In 2005 I became the General Partner of HealthCare 250 L.P. which was a long/short equity fund that concentrated investments in small to mid-cap health care companies.